POSTER SPOTLIGHT SESSIONS 1-18
- Session 1: New Insights into Immune Biomarkers - Wednesday December 11, 7-8:30 am. Location: Room 221ABC
- Session 2: Personalizing CDK 4/6 inhibitor therapy for patients with Metastatic Breast Cancer: Survival, QOL and biomarkers - Thursday, December 12, 7-8:30 am. Location: Hemisfair Ballroom 1-2
- Session 3: Highlights on Novel Therapeutics - Wednesday December 11, 7-8:30 am. Location: Stars at Night 1-2
- Session 4: Prediction of Chemotherapy Response - Wednesday December 11, 7-8:30 am. Location: Stars at Night 3-4
- Session 5: The Heart of the Matter - Improving Adverse Effects - Wednesday December 11, 7-8:30 am. Location: Hemisfair Ballroom 3
- Session 6: Locoregional Therapy - Thursday, December 12, 7-8:30 am. Location: Room 221ABC
- Session 7: Targeting the ER and PI3K pathway: Novel drugs and combinations - Wednesday December 11, 7-8:30 am. Location: Hemisfair Ballroom 1-2
- Session 8: Novel HER2 Therapeutics - Thursday, December 12, 7-8:30 am. Location: Stars at Night 1-2
- Session 9: ctDNA uses for Minimal Residual Disease testing, tumor evolution, and novel technologies - Thursday, December 12, 7-8:30 am. Location: Stars at Night 3-4
- Session 10: Addressing Racial Disparities in Breast Cancer Outcomes - Friday, December 13, 7-8:30 am. Location: Hemisfair Ballroom 3
- Session 11: Imaging to Guide Breast Cancer Treatment – Molecular Imaging and AI - Friday, December 13, 7-8:30 am. Location: Hemisfair Ballroom 1-2
- Session 12: Immunobiology Impact on Therapeutic Efficacy - Friday, December 13, 7-8:30 am. Location: Room 221ABC
- Session 13: Molecular determinants of therapeutic response and resistance - Spotight on CDK 4/6i and ADCs Location: Stars at Night 1-2
- Session 14: Brain Metastasis - Friday, December 13, 7-8:30 am. Location: Stars at Night 3-4
- Session 15: Survivorship – Biomarker predictors and other survival-associated factors- Thursday, December 12, 7-8:30 am. Location: Room 221ABC
- Session 16: Polygenic Risk - Thursday, December 12, 5:30-7 pm am. Location: Hemisfair Ballroom 3
- Session 17: Early Triple Negative Breast Cancer - Thursday, December 12, 5:30-7 pm am. Location: Stars at Night 1-2
- Session 18: Advancing our understanding of invasive lobular carcinoma: Potential to develop personalized therapeutic strategies? - Thursday, December 12, 5:30-7 pm am. Location: Stars at Night 3-4